Locke Bio Partners with imaware to Bring Comprehensive Lab Testing to Telehealth
Telehealth providers using Locke Bio can now offer seamless lab testing across all 50 states, eliminating the need for in-person visits.
LOS ANGELES, March 31, 2025 /PRNewswire/ — Locke Bio, a leading telehealth platform, has partnered with imaware, a premier lab-testing provider, to integrate comprehensive diagnostic testing into its digital healthcare ecosystem. This collaboration removes one of the final barriers to fully remote healthcare, allowing telehealth providers to offer lab-validated treatments without requiring patients to visit a doctor’s office.
With this integration, all Locke Bio enterprise clients can seamlessly add lab testing to their services, enabling faster diagnoses and more precise treatment plans across all 50 states. The company is transforming healthcare delivery by pairing this with Locke Bio’s advanced telehealth infrastructure, which includes secure payment processing, remote consultations, and prescription fulfillment.
Expanding Telehealth Beyond Traditional Boundaries
Earlier this year, Locke Bio launched Locke Bio Pay, a standalone, compliance-first payment solution explicitly built for telehealth. Developed in partnership with LegitScript, this solution has already helped over 80 companies achieve compliance certification, ensuring secure transactions for prescription sales via Visa, Mastercard, and American Express.
With imaware’s lab testing integration, Locke Bio further closes the gap between digital and in-person healthcare, allowing patients to complete critical health assessments from the comfort of their homes.
“This is a game-changer for telehealth,” said Cathy Tie, Founder & CEO of Locke Bio. “By adding imaware’s lab testing, we’re not just enhancing telehealth—we’re redefining what’s possible in digital medicine. Patients can now receive a full spectrum of care remotely, including diagnostic insights that previously required in-person visits.”
Lab-Validated Care for a Broader Range of Conditions
Many prescription treatments require lab testing to ensure patient safety and efficacy—especially for hormone therapies, chronic disease management, and specialized treatment protocols. Through imaware’s nationwide network of CLIA/CAP-certified labs, Locke Bio’s telehealth providers can now offer the same diagnostic certainty as traditional clinics.
Key Benefits of the Integration:
- Patients complete testing from home in under five minutes.
- Providers receive fast, lab-validated insights for precise treatment.
- No more scheduling hassles—patients avoid clinic visits and lost workdays.
- Built-in compliance ensures seamless regulatory adherence.
“With results in just a few days, patients gain vital health insights without ever stepping into a clinic, making proactive care easier than ever,” said Brodie Flanders, CEO of imaware. “This partnership removes friction from the diagnostic process, allowing patients and providers to focus on better health outcomes.”
Unlocking the Future of Digital-First Healthcare
This partnership positions Locke Bio at the forefront of a broader movement to bring complex healthcare services online. Telehealth providers using Locke Bio can now offer a comprehensive digital care experience—from patient onboarding and e-commerce solutions to diagnostics and treatment—making remote healthcare as effective as in-person visits.
Availability & Next Steps
The newly integrated lab testing services will be available to Locke Bio’s enterprise clients starting April 1, 2025. Companies interested in early integration can contact Locke Bio now to ensure seamless adoption.
About Locke Bio
Locke Bio is a digital health platform that helps enterprises launch compliant telehealth and online pharmacy solutions. Its white-label platform includes patient onboarding, e-commerce, doctor consultations, prescription fulfillment, lab testing, and the standalone Locke Bio Pay payment solution. A network of licensed doctors, pharmacies, and banks across the U.S. and Canada supports Locke Bio’s infrastructure. Learn more at https://lockebio.com.
About imaware
imaware empowers healthcare innovation by providing testing and technology solutions that scale. Its patient-facing platform offers home-based tests for men’s and women’s health, autoimmune diseases, preventative genetics, and more. imaware’s logistics, lab partnerships, and telehealth integrations create a seamless patient, provider, employer, and brand experience. Learn more at www.imaware.health
View original content:https://www.prnewswire.com/news-releases/locke-bio-partners-with-imaware-to-bring-comprehensive-lab-testing-to-telehealth-302408486.html
SOURCE Locke Bio
